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Mitochondrial Calpain-1 Disrupts
ATP Synthase and Induces Superoxide
Generation in Type 1 Diabetic Hearts:
A Novel Mechanism Contributing to
Diabetic Cardiomyopathy

Calpain plays a critical role in cardiomyopathic changes in
type 1 diabetes (T1D). This study investigated how calpain
regulates mitochondrial reactive oxygen species (ROS)
generation in the development of diabetic cardiomyopathy.
T1D was induced in transgenic mice overexpressing
calpastatin, in mice with cardiomyocyte-speciﬁc capn4
deletion, or in their wild-type littermates by injection
of streptozotocin. Calpain-1 protein and activity in mitochondria were elevated in diabetic mouse hearts. The
increased mitochondrial calpain-1 was associated with an
increase in mitochondrial ROS generation and oxidative
damage and a reduction in ATP synthase-a (ATP5A1) protein and ATP synthase activity. Genetic inhibition of calpain
or upregulation of ATP5A1 increased ATP5A1 and ATP synthase activity, prevented mitochondrial ROS generation and
oxidative damage, and reduced cardiomyopathic changes
in diabetic mice. High glucose concentration induced ATP
synthase disruption, mitochondrial superoxide generation,
and cell death in cardiomyocytes, all of which were prevented by overexpression of mitochondria-targeted calpastatin or ATP5A1. Moreover, upregulation of calpain-1
speciﬁcally in mitochondria induced the cleavage of ATP5A1,
superoxide generation, and apoptosis in cardiomyocytes.

Diabetes is a global metabolic disease and will affect nearly 400
million people by 2030 (1). Cardiovascular complications are
the most common cause of morbidity and mortality in patients with diabetes, and ;80% of all patients with diabetes
will die of cardiovascular diseases (2,3). Both type 1 and type 2
diabetes can directly affect cardiac structure and function in
the absence of changes in blood pressure and coronary artery
disease, a condition described as diabetic cardiomyopathy. In
the early stages, diabetic cardiomyopathy may present with
diastolic dysfunction and subsequently proceed to systolic dysfunction (4). The pathogenesis of diabetic cardiomyopathy is
incompletely understood, and limited treatment options exist.
Calpains belong to a family of calcium-dependent thiol
proteases (5). Fifteen gene products of the calpain family
are reported in mammals. Among them, calpain-1 and
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Mitochondrial Calpain-1 in Diabetic Hearts

RESEARCH DESIGN AND METHODS
Animals

This investigation conforms to the eighth edition of the
Guide for the Care and Use of Laboratory Animals published
by the U.S. National Institutes of Health. All experimental
procedures were approved by the Animal Use Subcommittee

at the University of Western Ontario (London, ON, Canada)
in accordance with the guidelines of the Canadian Council
for Animal Care. Breeding pairs of C57BL/6 mice and
db+/2 mice were purchased from The Jackson Laboratory
(Sacramento, CA). Transgenic mice with overexpression of
calpastatin (Tg-CAST; C57BL/6 background) were provided
by Laurent Baud (Institut National de la Santé et de la
Recherche Médicale, Paris, France) through the European
Mouse Mutant Archive (25). Mice with cardiomyocytespeciﬁc disruption of capn4 (capn4-ko) were generated as
described in our other report (7). All mice used in this study,
including controls, were littermates of the same generation.
Experimental Protocol

Type 1 diabetes was induced in adult male mice (2 months
old) by consecutive intraperitoneal injections of STZ
(50 mg/kg/day for 5 days) (7). Seventy-two hours after the
last injection of STZ, whole blood was obtained from the tail
vein and random glucose levels measured using the OneTouch
Ultra 2 blood glucose monitoring system (LifeScan, Inc.,
Milpitas, CA). Mice were considered diabetic and were used
for the study only if they had hyperglycemia ($15 mmol/L)
72 h after STZ injection. Citrate buffer–treated mice were
used as a nondiabetic control (blood glucose ,12 mmol/L).
Two months after induction of diabetes, mice (n = 8–12 per
group) were subjected to the following experiments.
Echocardiography

Animals were lightly anesthetized with inhaled isoﬂurane
(1%) and imaged with a 40-MHz linear array transducer
attached to a preclinical ultrasound system (Vevo 2100,
FUJIFILM VisualSonics, Toronto, ON, Canada) with
nominal inplane spatial resolution of 40 mm (axial) 3
80 mm (lateral). M-mode and two-dimensional parasternal
short-axis scans (133 frames/s) at the level of the papillary
muscles were used to assess changes in left ventricle (LV)
end-systolic inner diameter, LV end-diastolic inner diameter, and fractional shortening.
To assess diastolic function, we obtained apical fourchamber views of the LV. The pulsed wave Doppler
measurements of maximal early (E) and late (A) transmitral velocities in diastole were obtained in the apical
view with the cursor at mitral valve inﬂow.
Delivery of Adenoviral Vectors Into Mice

Mice were anesthetized with inhaled isoﬂurane (1–3%).
With the guide of echocardiography, adenoviral vectors
containing human ATP5A1 gene (Ad-ATP5A1, 2 3 109
plaque-forming units in 100 mL; SignaGen Laboratories,
Gaithersburg, MD) or green ﬂuorescent protein (Ad-GFP;
SignaGen Laboratories) were injected into mouse LV.
Isolation and Culture of Adult Mouse Cardiomyocytes

Adult mouse ventricle cardiomyocytes were isolated and
cultured as previously described (26).
Adenoviral Infection of Cardiomyocytes

Cardiomyocytes were infected with Ad-ATP5A1, adenoviral
vectors containing mitochondria-targeted rat calpastatin
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calpain-2 are ubiquitously expressed and well studied. Both
calpain-1 and calpain-2 consist of distinct, large 80-kDa
catalytic subunits encoded by capn1 and capn2, respectively,
and a common small 28-kDa regulatory subunit encoded by
capn4. The regulatory subunit is indispensable for calpain-1
and calpain-2 activities. Calpain-1 and calpain-2 are regulated by the endogenous calpain inhibitor calpastatin. We
reported previously that genetic inhibition of calpain by
overexpression of calpastatin or deletion of capn4 prevents
cardiomyocyte apoptosis and reduces cardiomyopathic
changes in mouse models of streptozotocin (STZ)-induced
type 1 diabetes (6,7), highlighting a critical role of calpain
in diabetic cardiomyopathy. However, the underlying mechanisms remain to be determined.
Although calpain-1 and calpain-2 have been considered
as mainly cytoplasmic enzymes, they are also present in
mitochondria (8,9). Hyperhomocysteinemia has been reported to induce the translocation of active calpain-1
from cytosol to mitochondria, which is associated with
intramitochondrial oxidative stress in cultured rat heart
microvascular endothelial cells (10), suggesting that calpain may regulate mitochondrial reactive oxygen species
(ROS) generation. This was supported by our recent study
demonstrating that inhibition of calpain prevents mitochondrial ROS generation in endothelial cells upon high
glucose stimulation (11). Calpains have been suggested to
target some important proteins in mitochondria, including, but not limited to, ATP synthase-a (ATP5A1) (12),
optic atrophy-1 (Opa-1) (13), apoptosis-inducing factor
(14), and Na+/Ca2+ exchanger-1 (NCX-1) (15). In diabetic
hearts, studies have shown that the protein levels of
ATP5A1 are reduced and that ATP synthase activity decreases (16,17). Disruption of these mitochondrial proteins may compromise mitochondrial function, resulting
in excessive ROS generation. In fact, mitochondrial ROS
production is increased in hearts of type 1 and type 2
diabetes models (17–20). Although mitochondrial superoxide generation is not increased in the heart of some
type 1 diabetic animals (21,22), selective inhibition of
mitochondrial ROS reduces cardiomyopathic changes in
type 1 diabetes (23,24). These studies raise an intriguing
hypothesis that calpain activation leads to excessive mitochondrial ROS generation in diabetic hearts, which contributes to diabetic cardiomyopathy.
In this study, we demonstrate that diabetes induces
calpain-1 accumulation in mitochondria of the heart. Increased calpain-1 in mitochondria is associated with ATP
synthase disruption, which stimulates mitochondrial ROS
generation and thus promotes diabetic cardiomyopathy in a
mouse model of STZ-induced type 1 diabetes.
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(Ad-mtCAST; SignaGen Laboratories), or b-gal (Ad-gal; Vector Biolabs, Philadelphia, PA) as a control at a multiplicity of
infection of 100 plaque-forming units/cell as previously
described (27).
Measurement of Mitochondrial Superoxide Generation

Construction of Plasmid With Mitochondria-Targeted
Capn1 Expression and Transfection in H9c2 Cells

The full coding region of human capn1 cDNA was recovered from pCMV6-XL5 containing human capn1
(OriGene, Rockville, MD) and inserted into pCMV/
myc/mito, which introduced the mitochondrial signal
peptide (Life Technologies Inc., Burlington, ON, Canada).
The resulting plasmid pCMV/myc/mito-capn1 expresses myc-tagged capn1 selectively in mitochondria. Rat
cardiomyocyte-like H9c2 cells were transfected with
pCMV/myc/mito-capn1 or pCMV/myc/mito as a control
by using the jetPRIME DNA transfection reagent (VWR
International, Mississauga, ON, Canada) according to the
manufacturer’s instructions.

257

wet weight of tissues) was used, and after homogenizing and centrifuging, trypsin inhibitor (0.5 mg/mL)
was added to the supernatant. The isolated mitochondria were further puriﬁed using Percoll density gradient centrifugation (30). Mitochondrial ROS generation
was determined on addition of pyruvate/malate or
succinate by using Amplex Red and horseradish peroxidase (Invitrogen) according to the manufacturer’s
instructions.
Determination of Oxidative Stress in Diabetic Hearts

The formation of ROS in heart tissue lysates was measured by using 2,7-dichlorodihydroﬂuorescein diacetate
(DCF-DA) (Invitrogen) (6) and Amplex Red as indicators according to the manufacturer’s instructions. The
protein oxidation in heart tissues was assessed by measuring protein carbonyl content using a commercial assay
kit (Cayman Chemical) according to the manufacturer’s
instructions. The antioxidant capacity was measured
based on reduction of copper (II) to copper (I) by using
an OxiSelect Total Antioxidant Capacity Assay Kit (Cell
Biolabs, Inc.).
Immunoﬂuorescence Staining and Confocal Microscopy

Mitochondrial smears were prepared on slides and ﬁxed
with freshly prepared 4% paraformaldehyde. After incubation with appropriate primary antibodies (capn1 and
VDAC-1) and secondary antibodies conjugated with differing ﬂuorescence (Alexa Fluor 488 donkey anti-mouse
IgG and Alexa Fluor 594 goat anti-rabbit IgG), signals
were obtained with an Olympus FV1000 confocal microscope equipped with an IX81 motorized inverted system
as described previously (31).

Calpain Activity

Co-immunoprecipitation and Native Gel Electrophoresis

Calpain activity was determined with a ﬂuorescence
substrate N-succinyl-LLVY-AMC (Cedarlane Laboratories,
Burlington, ON, Canada) as previously described (27).

Co-immunoprecipitation and nondenaturing PAGE were
carried out to analyze protein-protein interactions. Brieﬂy,
calpain-1 and its interacting proteins were coprecipitated
by using an immunoprecipitation kit (Dynabeads Protein
G; Life Technologies, Inc.), and ATP synthase complex was
isolated by using an ATP synthase immunocapture kit
(Abcam, Toronto, ON, Canada) in isolated mitochondria
according to the manufacturer’s instructions. Both calpain1/interacting proteins and ATP synthase complex were
subjected to nondenaturing PAGE for separation followed
by Western blot analysis.

Real-Time RT-PCR

Total RNA was extracted from heart tissues using TRIzol
reagent (Life Technologies Inc.), and real-time RT-PCR was
performed to analyze mRNA expression for atrial natriuretic peptide (ANP), b-MHC, and GAPDH as previously
described (7).
Western Blot Analysis

The protein levels of capn1, capn2, calpastatin, mitochondrial voltage-dependent anion channel (VDAC1),
ATP5A1 and b-subunits, and GAPDH were determined
by Western blot analysis using respective speciﬁc antibodies (Cell Signaling, Danvers, MA, and Santa Cruz Biotechnology, Dallas, TX).

ATP Synthase Activity

Measurement of ROS Generation in Freshly Isolated
Mitochondria

All data are presented as mean 6 SD. A one-way or twoway ANOVA followed by Newman-Keuls test was performed for multigroup comparisons as appropriate. For
comparison of two groups, unpaired t test was used. P ,
0.05 was considered statistically signiﬁcant.

Myocellular mitochondria were isolated from freshly harvested
hearts as described previously (29), with minor modiﬁcations as follows. Instead of nagarse, trypsin (5 mg/g

ATP synthase activity was measured by using an assay
coupled with pyruvate kinase, which converts ADP to ATP
and produces pyruvate from phosphoenolpyruvate as
described previously (32).
Statistical Analysis

Downloaded from http://diabetesjournals.org/diabetes/article-pdf/65/1/255/580105/db150963.pdf by guest on 22 June 2022

Superoxide ﬂashes in single mitochondrion were measured
to determine mitochondrial superoxide generation in living
cardiomyocytes as described previously (28). Brieﬂy, cardiomyocytes were infected with an adenoviral vector expressing mitochondria-targeted circularly permuted yellow
ﬂuorescent protein by using the cytochrome C oxidase
subunit IV–targeting sequence. Twenty-four hours after
infection, confocal images were recorded with an Olympus FV1000 laser-scanning microscope equipped with a
633 1.3 NA oil immersion objective and a sampling rate
of 0.7 s/frame. At least 20 cardiomyocytes per culture in
each group were analyzed.
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RESULTS
Mitochondrial ROS Generation Is Increased in Diabetic
Mouse Hearts and High Glucose–Stimulated
Cardiomyocytes

Diabetes Volume 65, January 2016

elevated in mitochondria from diabetic hearts in a timedependent manner (Fig. 3A). Consistently, diabetes also
increased calpain activities in mitochondria of diabetic versus sham animal hearts (Supplementary Fig. 2). However,
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To determine mitochondrial ROS generation in cardiomyocytes under diabetic conditions, we made wild-type
mice diabetic by injection of STZ. At 0, 7, 28, and 60 days
after STZ injection, we isolated mitochondria from mouse
hearts and determined mitochondrial H2O2 generation.
As shown in Fig. 1A, H2O2 generation in isolated mitochondria was increased in a time-dependent manner by
using pyruvate/malate as substrates. Similarly, in cultured
adult cardiomyocytes, high glucose (30 mmol/L) incubation increased mitochondrial superoxide generation in a
time-dependent manner (Fig. 1B). These results conﬁrm
that mitochondrial ROS generation is increased in cardiomyocytes under diabetic conditions.
Genetic Inhibition of Calpain Prevents Mitochondrial
ROS Generation and Reduces Oxidative Damage in
Diabetic Mouse Hearts

We have reported that genetic inhibition of calpain reduces
diabetic cardiomyopathy in mouse models of type 1
diabetes (6,7). To understand the underlying mechanisms,
we determined whether calpain plays a role in mitochondrial ROS generation. To this end, we ﬁrst incubated cultured cardiomyocytes from Tg-CAST and wild-type mice
with normal or high glucose concentrations for 24 h. Overexpression of calpastatin signiﬁcantly decreased mitochondrial superoxide generation induced by high glucose
concentrations in Tg-CAST cardiomyocytes (Fig. 1C). This
result provides direct evidence that inhibition of calpain by
overexpressing calpastatin blunts high glucose–stimulated
superoxide generation in cardiomyocytes.
We then made Tg-CAST and capn4-ko and their wildtype mice diabetic by injection of STZ. Sixty days after STZ
injection, calpastatin overexpression and capn4 deletion
signiﬁcantly reduced H2O2 generation in mitochondria
from STZ-treated Tg-CAST and capn4-ko mice, respectively,
after the addition of pyruvate/malate (Fig. 2A and B) or
succinate (Supplementary Fig. 1A and B). Similarly, H2O2
formation as determined by using DCF-DA (Fig. 2C and D)
and Amplex Red (Fig. 2E and F) and the protein carbonyl
content (Fig. 2G and H) were increased in diabetic mouse
hearts and abrogated in Tg-CAST and capn4-ko mice, respectively. However, total antioxidant capacity was comparable among wild-type, Tg-CAST, and capn4-ko mice after
induction of diabetes (data not shown). These results suggest that calpain contributes to mitochondrial ROS generation and oxidative damage in diabetic hearts.
Calpain-1 Is Increased in Mitochondria of STZ-Induced
Diabetic Mouse Hearts

Having shown that inhibition of calpain prevented mitochondrial superoxide generation, we determined whether the
calpain levels were altered in mitochondria of diabetic mouse
hearts. In line with the increase in mitochondrial ROS
generation, the protein levels of capn1 were signiﬁcantly

Figure 1—Determination of mitochondrial ROS generation. A: Adult
wild-type (WT) mice were injected with STZ 50 mg/kg/day i.p. for 5
days. Mice were killed 1 week, 1 month, and 2 months after STZ
injection. Mitochondria were isolated from heart tissues. Mitochondrial H2O2 generation was determined by using Amplex Red as an
indicator after addition of pyruvate/malate. B and C: Adult cardiomyocytes were isolated and cultured for up to 24 h. B: Time course
of mitochondrial superoxide ﬂashes after incubation with a high
glucose (HG) concentration (30 mmol/L) in WT cardiomyocytes.
C: Twenty-four hours after incubation with HG (30 mmol/L) or normal glucose (NG) (5 mmol/L), mitochondrial superoxide ﬂashes
were analyzed in WT and Tg-CAST mice. Data are mean 6 SD
(n = 6 or three separate cultures). *P < 0.05 vs. sham, 0 h, or NG
in WT; #P < 0.05 vs. HG in WT.
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Figure 2—Assessment of mitochondrial ROS generation and oxidative stress. Wild-type (WT), Tg-CAST, or cardiomyocyte-speciﬁc capn4ko mice were injected with STZ 50 mg/kg/day i.p. for 5 days. Two months after STZ injection, mitochondria were isolated from heart
tissues. Mitochondrial ROS generation was measured using Amplex Red after addition of pyruvate/malate (A and B). ROS formation in
heart tissue lysates was determined by using DCF-DA as an indicator (C and D) or Amplex Red (E and F). Oxidative damage was assessed
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Mitochondrial Calpain-1 Contributes to Superoxide
Generation and Cell Death in High Glucose–Stimulated
Cardiomyocytes

To determine whether mitochondrial calpain-1 contributes to superoxide generation in cardiomyocytes, we
infected cultured cardiomyocytes with Ad-mtCAST and
incubated them under high glucose conditions for 24 h.
Selective overexpression of calpastatin in mitochondria
prevented mitochondrial superoxide ﬂashes and cell death
induced by high glucose concentrations (Fig. 4A–D). This
result suggests that mitochondrial calpain contributes to
superoxide generation and cell death induced by high glucose levels in cardiomyocytes.
To provide direct evidence to support our hypothesis
that the accumulation of calpain-1 in mitochondria induces superoxide generation and apoptosis, we introduced
pCMV/myc/mito-capn1, a plasmid expressing mitochondria-targeted capn1 into cardiomyocyte-like H9c2 cells.
Twenty-four hours after transfection, mitochondrial and
cytosolic fractions were isolated from H9c2 cells. Overexpressed capn1 was conﬁrmed in mitochondrial but not in
cytosolic fractions (Fig. 5A). Of note, mitochondriatargeted overexpression of capn1 signiﬁcantly increased
mitochondrial superoxide generation as determined by mitochondrial superoxide ﬂashes (Fig. 5B) and induced apoptosis (Fig. 5C and D). These results strongly support a
causal role of mitochondrial calpain-1 in superoxide generation and apoptosis in cardiomyocytes.
ATP5A1 Is a Target of Calpain-1 in Diabetic Hearts

Because studies have shown that the protein levels of
ATP5A1 are reduced and ATP synthase activity decreases
in diabetic hearts (16,17), our initial effort was focused on
ATP5A1. After incubation of mitochondrial lysates from
the heart with active calpain-1, a cleaved fragment of
ATP5A1 protein (;38 kD) was detected (Fig. 5E). Of
note, upregulation of calpain-1 selectively in mitochondria led to a similar cleaved fragment of ATP5A1 protein

in H9c2 cells (Fig. 5F). These results strongly indicate that
ATP5A1 protein is a direct substrate of calpain-1.
We further revealed that ATP5A1 was co-immunoprecipitated with capn1 in diabetic hearts (Fig. 6A). Likewise,
capn1 was detected in immune-captured ATP synthase
complex (Fig. 6B). These results demonstrate a potential
interaction between calpain-1 and ATP5A1 in mitochondria of diabetic hearts. We also measured the protein levels
of ATP5A1 in isolated mitochondria of diabetic hearts. Diabetes signiﬁcantly reduced ATP5A1 protein levels in mitochondria (Fig. 6C), which is consistent with previous
reports (16,17), whereas the protein levels of ATP synthase
b-subunit remained unchanged in diabetic hearts (Fig. 6C).
However, the reduction in ATP5A1 protein levels was prevented by calpastatin overexpression (Fig. 6D). In line with
a reduction in ATP5A1 protein, ATP synthase activity was
markedly decreased in mitochondria from diabetic hearts
and restored in diabetic Tg-CAST mice (Fig. 6E).
In cultured cardiomyocytes, overexpression of calpastatin selectively in mitochondria by infection with AdmtCAST signiﬁcantly increased ATP synthase activity
during high glucose stimulation (Fig. 6F). This result provides further evidence to support that calpain activation
disrupts ATP synthase activity in diabetic hearts.
Overexpression of ATP5A1 Reduces Mitochondrial
Superoxide Generation, Cardiac Hypertrophy, and
Myocardial Dysfunction in Diabetic Mice

To investigate whether upregulation of ATP5A1 protects
diabetic hearts, we delivered Ad-ATP5A1 into mice 72 h
after the last STZ injection. Ad-GFP served as a control.
Two weeks later, mice received the second dose of AdATP5A1. Two months after STZ injection, mice were
subjected to various experiments. The efﬁcient delivery of
adenoviral vectors into the heart was conﬁrmed by the GFP
signal in heart tissues (Supplementary Fig. 3). As a result,
delivery of Ad-ATP5A1 signiﬁcantly increased ATP5A1 protein and ATP synthase activity in diabetic mouse hearts
(Fig. 7A and B), suggesting that ectopic expression of
ATP5A1 integrates into the complex of ATP synthase. Upregulation of ATP5A1 reduced the formation of H2O2 (Fig. 7C
and D) and attenuated cardiac hypertrophy as evidenced by
decreased cardiomyocyte sectional area (Fig. 7E) and downregulation of ANP and b-MHC expression in diabetic mouse
hearts (Fig. 7F and G), leading to an improvement of myocardial function in diabetic mice as determined by the increased fractional shortening and E/A ratio (Fig. 7H and I
and Supplementary Table 1). However, delivery of AdATP5A1 slightly elevated ATP5A1 protein levels in sham
mouse hearts but did not increase ATP synthase activity.
To provide further evidence to support the role of
ATP5A1, we infected adult cardiomyocytes with Ad-ATP5A1

by measuring protein carbonyl contents in heart tissue lysates (G and H). Data are mean 6 SD (n = 6). *P < 0.05 vs. sham in WT; #P < 0.05
vs. STZ-treated WT.
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diabetes did not change the protein levels of capn2 and
calpain-10, an isoform well recognized as a mitochondrial
calpain (33) (data not shown).
To provide further evidence in support of calpain-1
accumulation in mitochondria, we determined capn1 and
VDAC1 proteins in isolated mitochondria of diabetic mouse
hearts by dual immunoﬂuorescence confocal microscopy.
Confocal microscopic analysis demonstrated that VDAC1
was detected in mitochondrial membranes (red), that capn1
was present inside mitochondria (green), and that percentages of capn1-labeled mitochondria were much greater in
diabetic versus sham mouse hearts (Fig. 3B). Similarly, the
protein levels of capn1 were also increased in hearts of db/db
type 2 diabetic versus db+/2 mice (Fig. 3C).
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Figure 3—Measurement of calpain-1 in mitochondria. A: Adult wild-type mice were injected with STZ 50 mg/kg/day i.p. for 5 days. Mice
were killed 1 week, 1 month, and 2 months after STZ injection. Mitochondria were isolated from heart tissues, and the protein levels of
calpain-1 and VDAC1 in mitochondria were determined by Western blot analysis. The top panel is the representative Western blot for capn1
and VDAC1 from two of six hearts in each group, and the bottom panel is the quantiﬁcation of capn1/VDAC1 in all animals. B: Adult wildtype mice were injected with STZ 50 mg/kg/day i.p. for 5 days. Two months after STZ injection, heart tissues were collected and
mitochondria isolated. After ﬁxation on slides, dual immunoﬂuorescent staining for VDAC1 and capn1 was performed by using their
respective antibodies followed by secondary antibodies conjugated with different ﬂuorescent dyes. Representative photomicrographs of
confocal microscopy for VDAC1 and capn1 in mitochondria show membrane staining of VDAC1 (red) and that capn1 is located in
mitochondria (green). C: Mitochondria were isolated from db/db type 2 diabetic and db+/2 mouse hearts (male and age 3.5 months).
The protein levels of capn1 and VDAC1 were determined by Western blot analysis. The left panel is a representative Western blot for capn1
and VDAC1 from three of six hearts in each group, and the right panel is the quantiﬁcation of capn1 protein normalized to VDAC1. Data are
mean 6 SD from six different heart tissues in each group. *P < 0.05 vs. sham.
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or Ad-gal as a control and then incubated them under
high glucose conditions for 24 h. Upregulation of ATP5A1
increased ATP synthase activity in high glucose– but not
normal glucose–stimulated cardiomyocytes (Fig. 8A), reduced mitochondrial superoxide generation (Fig. 8B), and
prevented cell death induced by high glucose levels (Fig.
8C and D).
DISCUSSION

The major ﬁndings of this study are that genetic inhibition
of calpain increases the protein levels of ATP5A1 and ATP
synthase activity and decreases mitochondrial ROS generation and oxidative damage in diabetic hearts. Both type 1
and type 2 diabetes induce calpain-1 accumulation in
mitochondria of the heart. Selective inhibition of mitochondrial calpain attenuates ATP synthase disruption, reduces mitochondrial superoxide generation, and prevents
apoptosis in cardiomyocytes under diabetic conditions,
whereas targeted upregulation of calpain-1 speciﬁcally in
mitochondria induces the cleavage of ATP5A1, superoxide
generation, and apoptosis in cardiomyocytes. In a mouse
model of type 1 diabetes, upregulation of ATP5A1 restores

ATP synthase activity and decreases mitochondrial ROS
generation in diabetic hearts and reduces diabetic cardiomyopathy. Thus, ATP synthase disruption and mitochondrial ROS generation are important mechanisms by which
calpain activation promotes diabetic cardiomyopathy.
Accumulating evidence indicates that mitochondrial
ROS production is increased and oxidative stress occurs in
type 1 and type 2 diabetic hearts (17–20). Although some
type 1 diabetic animals did not exhibit increased mitochondrial superoxide generation in the heart (21,22), selective inhibition of mitochondrial ROS production
reduces adverse cardiac changes in type 1 diabetes models
(23,24), supporting a critical role of mitochondrial ROS.
The current study demonstrates that diabetic conditions
induce mitochondrial superoxide generation in cultured
cardiomyocytes and hearts in vivo. ROS produced by mitochondria not only directly contributes to mitochondrial
dysfunction (34), cell death, and hypertrophy in cardiomyocytes and hearts under stress (35,36) but also serves
as second messengers in cellular signaling pathways (37).
Thus, targeted inhibition of mitochondrial ROS by transgenic overexpression of superoxide dismutase 2 and
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Figure 4—Effects of mitochondria-targeted calpastatin overexpression on mitochondrial superoxide ﬂashes and cell death in high glucose–
stimulated cardiomyocytes. A: H9c2 cells were infected with Ad-mtCAST or Ad-gal as control. Twenty-four hours later, mitochondrial and
cytosolic fractions were prepared, and calpastatin (CAST), GAPDH, and VDAC1 were detected by Western blot analysis. A representative
Western blot conﬁrmed that myc-tagged CAST is expressed selectively in mitochondria. B–D: Adult cardiomyocytes were isolated from
mice. After infection with Ad-mtCAST, cardiomyocytes were exposed to normal glucose (NG) or high glucose (HG) for 24 h, and mitochondrial
superoxide ﬂashes (B) and annexin V staining for cell death (C and D) were determined. Data are mean 6 SD from six different cultures.
*P < 0.05 vs. NG + Ad-gal; #P < 0.05 vs. HG + Ad-gal.
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mitochondrial catalase reduces cardiac hypertrophy, preserves cardiac structures, and improves function in a
mouse model of type 1 diabetes (23) and in insulinresistant and obese Ay mice (24), respectively. We further
show that genetic inhibition of calpain signiﬁcantly attenuates mitochondrial superoxide generation and subsequent
oxidative damage in diabetic mouse hearts, which are associated with reduced myocardial injury and improved
myocardial function in diabetic mice. Thus, the data suggest an important role of calpain in mitochondrial ROS
generation in the development of diabetic cardiomyopathy.
It is well known that mitochondria generate superoxide, the primary ROS by-product, when single electrons
leak to react with molecular oxygen (38). Although many
mitochondrial enzymes have been reported to produce
ROS, the respiratory chain is the major source of ROS
in mitochondria. Within the respiratory chain, complexes
I and III have been identiﬁed as major ROS generators.
On the other hand, mitochondrial ROS is eliminated by
antioxidant defense systems. Superoxide anion dismutates

to H2O2 spontaneously or by superoxide dismutase 2 in
mitochondria. H2O2 can be readily converted to water by
catalase and glutathione peroxidase. In addition to these
antioxidant enzymes, mitochondria possess several lowmolecular-weight antioxidants, including a-tocopherol
and ubiquinol. An increase in superoxide generation
and/or a decrease in antioxidant capacity will lead to oxidative stress in mitochondria (39). In this regard, the
current data suggest that calpain promotes oxidative
damage through increased mitochondrial superoxide generation rather than decreased antioxidant capacity because inhibition of calpain does not affect antioxidant
capacity in diabetic hearts.
Multiple mechanisms have been suggested to mediate
mitochondrial ROS generation in diabetic hearts. It was
reported that high glucose concentrations increased
metabolic input into mitochondria, which overwhelms
the respiratory chain, causing mitochondrial hyperpolarization and leading to electron backup within the
respiratory chain and to ROS overproduction (38). In
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Figure 5—Effects of mitochondrial targeted capn1 on ATP5A1 protein, superoxide generation, and apoptosis in H9c2 cells. H9c2 cells
were transfected with pCMV/myc/mito-capn1 (mt-Capn1) or pCMV/myc/mito as a control. A: Twenty-four hours later, mitochondrial and
cytosolic fractions were isolated. Western blot analysis was performed to determine the protein levels of capn1, GAPDH, and VDAC1. B:
Mitochondrial superoxide ﬂashes were assessed. C and D: Apoptosis was determined by caspase-3 activity and DNA fragmentation. E and
F: ATP5A1 and its cleaved fragment were determined by Western blot analysis. E: Mitochondrial lysates (100 mg) were incubated with
active calpain-1 (5 mg) for 15 min. F: ATP5A1 immunoblot in H9c2 cells transfected with mt-Capn1. Data are mean 6 SD from at least three
different experiments. *P < 0.05 vs. control.
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addition, elevated circulating lipid levels and hyperinsulinemia together increase fatty acid delivery to cardiomyocytes, which rapidly adapt by promoting fatty acid
utilization. High rates of fatty acid oxidation increase mitochondrial membrane potential, leading to the production of
ROS in mitochondria (40,41). In the current study, we show
that diabetes increases calpain-1 in mitochondria, and
calpain-1 accumulation in mitochondria correlates with ROS
generation in diabetic mouse hearts. Selective inhibition of
mitochondrial calpain also reduces superoxide generation in
cardiomyocytes under diabetic conditions, whereas targeted
overexpression of capn1 in mitochondria sufﬁciently induces
superoxide generation in cardiomyocytes. Thus, mitochondrial calpain-1 may represent a novel mechanism underlying
mitochondrial ROS generation in cardiomyocytes under diabetic conditions.

Another important ﬁnding is that mitochondrial
calpain-1 negatively regulates ATP5A1 protein, leading to
ATP synthase disruption in diabetic hearts. ATP synthase,
also called complex V, is an enzyme that uses the energy
created by the proton electrochemical gradient to synthesize ATP from ADP (42). It is located within the mitochondria. ATP synthase comprises two regions: the Fo portion
and the F1 portion. The Fo region of ATP synthase is a
proton pore located within the inner membrane of mitochondria, which transfers the energy created by the proton
electrochemical gradient to F1 where ADP is phosphorylated to ATP. The F1 region of ATP synthase comprises
ﬁve subunits (a, b, g, d, and e) in the matrix of the mitochondria. Downregulation of ATP synthase has been shown
in both type 1 and type 2 diabetic hearts (16,17). Similarly,
we show a signiﬁcant reduction of ATP5A1 protein and of
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Figure 6—Role of calpain in ATP5A1 expression and ATP synthase disruption in diabetic hearts. A: Interaction between ATP5A1 and
capn1. Capn1-interacting proteins were co-immunoprecipitated by using capn1 antibody. A representative Western blot shows that
ATP5A1 is detected in capn1-interacting proteins. B: ATP synthase complex and its interacting proteins were captured with an ATP
synthase immune capture assay kit. A representative Western blot shows that capn1 is detected in captured ATP synthase complex.
C–E: Myocardial mitochondria were isolated from sham and STZ-injected Tg-CAST and their wild-type (WT) mice (C and D). The top panels
are the representative Western blots for ATP5A1 protein from three of six hearts in each group, and the bottom panels are the quantiﬁcation
of ATP5A1 protein relative to VDAC1 in mitochondria. E: ATP synthase activity was measured in mitochondria. Data are mean 6 SD (n = 6).
*P < 0.05 vs. sham or STZ + WT; #P < 0.05 vs. STZ + WT. F: Adult cardiomyocytes were isolated and cultured from WT mice. After
infection with Ad-mtCAST or Ad-gal, the cells were incubated with high glucose (HG) (30 mmol/L) or normal glucose (NG) (5 mmol/L)
concentrations for 24 h. ATP synthase activity was determined in cell lysates. Data are mean 6 SD (n = 6). *P < 0.05 vs. NG + Ad-gal; #P <
0.05 vs. HG + Ad-gal. IP, immunoprecipitation.
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its activity in mitochondria from diabetic mouse hearts.
Diabetes-induced downregulation of ATP5A1 and ATP
synthase activity are prevented by both calpastatin overexpression and capn4 deletion. Thus, our observations are
consistent with a model whereby calpain-1 accumulation
in mitochondria compromises ATP synthase through the
proteolysis of ATP5A1 protein in diabetic mouse hearts. In
fact, selective upregulation of calpain-1 in mitochondria induces the cleavage of ATP5A1 protein, mitochondrial superoxide generation, and apoptosis in cultured cardiomyocytes.
Although we could not detect Opa-1 and NCX-1 protein
in calpain-1 immunoprecipitates (data not shown),
calpain-1 may also target other substrates in mitochondria. For example, calpain-1 has been reported to
cleave apoptosis-inducing factor, leading to apoptosis during ischemia/reperfusion injury in the heart (14). Thus,
it is possible that multiple targets of calpain-1 exist in

mitochondria of diabetic hearts, which merits further
investigation.
Disruption of ATP synthase within complex V results
in excess electron backup in the individual electron
transfer complexes (34), particularly complex I and III,
promoting mitochondrial superoxide generation. Indeed,
an increase in reverse electron ﬂow and electrons leaking
from complex I and III of the respiratory chain has been
suggested to be the main mechanism promoting mitochondrial ROS generation in diabetes (40,41). Disruption
of ATP synthase also induces insufﬁcient ATP production,
which directly contributes to myocardial dysfunction. In
support of this view, we show that upregulation of
ATP5A1 increases ATP synthase activity, decreases mitochondrial ROS generation, and mitigates diabetic cardiomyopathy. Taken together, we observed that calpain-1
mediates mitochondrial superoxide generation, at least
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Figure 7—Effects of ATP5A1 overexpression in diabetic cardiomyopathy. Adult mice were injected with Ad-ATP5A1 or Ad-GFP and then
treated with STZ. A: Upregulation of ATP5A1 protein was conﬁrmed by Western blot analysis. Top panel is a representative Western blot
from two of six hearts for ATP5A1 and VDAC1, and the bottom panel is the quantiﬁcation of the ATP5A1/GAPDH ratio for all hearts. B: ATP
synthase activity. C and D: H2O2 formation was determined in heart tissue lysates by using Amplex Red (C) and DCF-DA as indicators (D).
E: Cardiomyocyte size in heart sections. F: The mRNA levels of b-MHC. G: The mRNA levels of ANP. H and I: Echocardiographic analysis
was performed to assess myocardial function. Data are mean 6 SD (n = 6–8). *P < 0.05 vs. sham + Ad-GFP; #P < 0.05 vs. STZ + Ad-GFP.
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partly by downregulation of ATP5A1 and disruption of
ATP synthase, leading to cardiomyopathic changes in diabetic mice. Overexpression of ATP5A1 per se is not sufﬁcient to increase ATP synthase activity, but it prevents a
diabetes/hyperglycemia-induced decrease in its activity in
cardiomyocytes.
In the current study, STZ was given in multiple low
doses to induce type 1 diabetes in mice. In this model, an
inﬂammatory response occurs in the b-cells, leading to
lymphocytic inﬁltrates and cell death (43), which effectively models the autoimmune T-cell–mediated destruction and hypoinsulinemia observed in human type 1
diabetes (44). Because mitochondrial capn1 protein is
also elevated in db/db type 2 diabetic mouse hearts, similar mechanisms may be operating in type 2 diabetic cardiomyopathy, which requires further study for clariﬁcation.
Future study is also needed to determine whether mitochondrial calpain is increased and contributes to diabetic
cardiomyopathy in humans.
Although the current study focuses on mitochondrial
calpain-1 and ROS generation, other mechanisms may
also be involved in calpain-mediated diabetic cardiomyopathy. In particular, calpain activation may induce the
cleavages of important cytosolic proteins, including signaling molecules (protein kinase C and nuclear factor-kB)
(45,46), calcium regulatory proteins (47,48), and myoﬁbril proteins (49,50), which may contribute to myocardial
dysfunction in diabetes.

In summary, this study demonstrates that mitochondrial calpain-1 stimulates mitochondrial ROS generation
through downregulation of ATP5A1 and disruption of ATP
synthase, which promotes diabetic cardiomyopathy. These
ﬁndings uncover a novel mechanism underlying diabetic
cardiomyopathy, which may have signiﬁcant implications
in diabetic cardiac complications.
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Figure 8—Role of ATP5A1 in ATP synthase activity, mitochondrial superoxide generation, and cell death in cardiomyocytes. Adult mouse
cardiomyocytes were isolated from wild-type mice. After attachment to the culture dish, cells were infected with Ad-ATP5A1 or Ad-gal.
Twenty-four hours later, cells were incubated with normal glucose (NG) or high glucose (HG) concentrations for 24 h. A: ATP synthase
activity. B: Mitochondrial superoxide generation. C: Representative pictures for annexin V–positive cells as an indicator of cell death (green).
D: Quantiﬁcation of annexin V–positive cells. Data are mean 6 SD from at least three different experiments. *P < 0.05 vs. Ad-gal + NG; #P
< 0.05 vs. Ad-gal + HG.
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